NextMeds review

NextMeds for moms: our verdict

Compounded semaglutide at $79 a month and tirzepatide at $119, month to month, with no dose-based increase and — checked in its own checkout data rather than taken on trust — a renewal price identical to the joining price. That last part is rarer than it should be. Two things the homepage will not tell you. The $49 and $99 it advertises are the twelve-month totals divided by twelve, not a monthly rate you can start on, and the countdown beside them is not a real deadline: it read August 15th and then August 20th within the same hour. The larger caveat is corporate. NextMeds is operated by Trinity HealthCare Supply, LLC, which also runs Lean Meds, altRx and Trinity Meds, and that operator holds an open FDA warning letter. It runs about $79/mo, flat across every dose — toward the affordable end of what we track.

We looked at NextMeds the way moms actually have to: not just the monthly cost, but the right timing around pregnancy and nursing and honest, clear pricing from the start — the parts a generic weight-loss review skips.

What NextMeds actually costs

• Compounded semaglutide — Injection, month to month: $79/mo
• Compounded semaglutide — Injection, 3-month plan: $76/mo
• Compounded semaglutide — Injection, 6-month plan: $73/mo
• Compounded semaglutide — Injection, 12-month plan: $49/mo
• Compounded tirzepatide — Injection, month to month: $119/mo
• Compounded tirzepatide — Injection, 3-month plan: $115/mo

That lands below the median ongoing price of about $179 across the providers we track for moms — a real cost advantage.

NextMeds prices flat across doses, so it doesn't climb as your dose does — which matters, because most women spend months titrating up.

That price covers the consult and the medication.

The medications NextMeds prescribes

NextMeds prescribes semaglutide and tirzepatide — the two molecules with the strongest published weight-loss results, and having both on one account matters when insulin resistance (common with PCOS and after gestational diabetes) makes tirzepatide the better fit. These are compounded formulas from a licensed pharmacy — the reason the price stays low — but compounded GLP-1s are not FDA-approved finished products the way Wegovy and Zepbound are.

Where it operates. NextMeds lists its coverage as: All 50 states.

Where NextMeds fits — and where it doesn't — for moms

A good fit if…

• you want a real clinician who reads your history with the right timing around pregnancy and nursing in mind, not a questionnaire that approves you automatically.
• the monthly cost is a real barrier and you want a low, predictable number.
• you may need to switch between semaglutide and tirzepatide as your body and your hormones change.
• uninterrupted nationwide access matters to you — a move for the family shouldn't interrupt your care.

Look elsewhere if…

• you specifically want an FDA-approved brand-name pen with its own pregnancy and breastfeeding label.
• a clean regulatory record is non-negotiable for you — look at the FDA warning letter flagged in the cons above.

Trust, safety and oversight

Our confidence in NextMeds's public data is high — the pricing, the pharmacies and the clinical network were all verifiable at our last review. It has an FDA warning letter, flagged in the cons — read it before you start. As with any compounded GLP-1, the most useful thing moms can do is confirm which licensed pharmacy fills the prescription and what's in the formula — we explain how we score oversight in our scoring methodology.

A standing caution for moms: GLP-1 medications are not proven safe during pregnancy or breastfeeding, and every label advises against use. None of this changes that — plan the timing with your own healthcare provider.

The bottom line

NextMeds is a genuine bargain for the price — weigh it on the right timing around pregnancy and nursing and honest, clear pricing from the start against the alternatives below. For most moms, CoreAge Rx is still the best choice overall — see why it tops our ranking.